ATE406873T1 - Zusammensetzung zur behandlung entzündlicher erkrankungen - Google Patents

Zusammensetzung zur behandlung entzündlicher erkrankungen

Info

Publication number
ATE406873T1
ATE406873T1 AT03733628T AT03733628T ATE406873T1 AT E406873 T1 ATE406873 T1 AT E406873T1 AT 03733628 T AT03733628 T AT 03733628T AT 03733628 T AT03733628 T AT 03733628T AT E406873 T1 ATE406873 T1 AT E406873T1
Authority
AT
Austria
Prior art keywords
treatment
composition
inflammatory diseases
forming lipids
liposomes
Prior art date
Application number
AT03733628T
Other languages
English (en)
Inventor
Josbert Metselaar
Original Assignee
Enceladus Pharmaceuticals B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enceladus Pharmaceuticals B V filed Critical Enceladus Pharmaceuticals B V
Application granted granted Critical
Publication of ATE406873T1 publication Critical patent/ATE406873T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03733628T 2002-06-12 2003-06-11 Zusammensetzung zur behandlung entzündlicher erkrankungen ATE406873T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02077338A EP1371362A1 (de) 2002-06-12 2002-06-12 Zusammensetzung zur Behandlung entzündlicher Erkrankungen

Publications (1)

Publication Number Publication Date
ATE406873T1 true ATE406873T1 (de) 2008-09-15

Family

ID=29558396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03733628T ATE406873T1 (de) 2002-06-12 2003-06-11 Zusammensetzung zur behandlung entzündlicher erkrankungen

Country Status (8)

Country Link
EP (2) EP1371362A1 (de)
JP (1) JP4564844B2 (de)
AT (1) ATE406873T1 (de)
AU (1) AU2003238716B2 (de)
CA (1) CA2489269C (de)
DE (1) DE60323369D1 (de)
ES (1) ES2314210T3 (de)
WO (1) WO2003105805A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002045688A2 (en) 2000-12-07 2002-06-13 Universiteit Utrecht Holding B.V. Composition for treatment of inflammatory disorders
DE10255106A1 (de) * 2002-11-24 2004-06-09 Novosom Ag Liposomale Glucocorticoide
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US7744920B2 (en) * 2004-09-09 2010-06-29 Hadasit Medical Research Services & Development Limited Use of liposomal glucocorticoids for treating inflammatory states
CA2595731A1 (en) * 2005-01-26 2006-08-03 Celator Pharmaceuticals, Inc. Lipid carrier compositions with reduced polydispersity
EP2127639A1 (de) * 2008-05-26 2009-12-02 Universiteit Utrecht Holding B.V. Corticosteroid enthaltende Liposomen zur Behandlung von kardiovaskulären Erkrankungen
WO2010148262A1 (en) * 2009-06-17 2010-12-23 Mark Rutenberg Treatment of acute pulmonary inflammation induced by cigarette smoking
WO2011150392A1 (en) 2010-05-28 2011-12-01 Purdue Research Foundation Delivery of therapeutic agents to inflamed tissues using folate-targeted agents
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
US9144575B2 (en) 2010-07-28 2015-09-29 Life Technologies Corporation Anti-viral azide containing compounds
US10471010B2 (en) 2011-11-04 2019-11-12 Enceladus Pharmaceuticals B.V. Liposomal corticosteroids for treatment of inflammatory disorders in humans
SG11201404361UA (en) 2012-01-26 2014-09-26 Life Technologies Corp Methods for increasing the infectivity of viruses
HRP20230655T1 (hr) 2012-07-05 2023-10-13 Taiwan Liposome Company, Ltd. Metode liječenja artritisa
CN109906075A (zh) 2016-04-29 2019-06-18 恩瑟拉德斯医药有限公司 用于在发炎病灶或区域中局部注射的脂质体皮质类固醇
KR20210060559A (ko) * 2018-09-16 2021-05-26 티엘씨 바이오파머슈티컬즈 인코포레이티드 관절 전달에 적합한 약학 조성물 및 관절통 치료에서의 이의 용도
US11304901B2 (en) * 2019-08-28 2022-04-19 Anovent Pharmaceutical (U.S.), Llc Liposome formulation of fluticasone furoate and method of preparation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
US6316260B1 (en) * 1997-08-22 2001-11-13 Bernina Biosystems Gmbh Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof
JP4827277B2 (ja) * 1998-11-02 2011-11-30 テルモ株式会社 リポソーム
CN1320880C (zh) * 1998-12-23 2007-06-13 伊迪亚股份公司 改进的体内局部无创伤用制剂
DE60042159D1 (en) * 1999-06-25 2009-06-18 Terumo Corp Liposome
JP2001064158A (ja) * 1999-06-25 2001-03-13 Terumo Corp リポソーム
WO2002045688A2 (en) * 2000-12-07 2002-06-13 Universiteit Utrecht Holding B.V. Composition for treatment of inflammatory disorders

Also Published As

Publication number Publication date
JP4564844B2 (ja) 2010-10-20
DE60323369D1 (de) 2008-10-16
EP1517675A1 (de) 2005-03-30
AU2003238716B2 (en) 2009-10-08
EP1517675B1 (de) 2008-09-03
WO2003105805A1 (en) 2003-12-24
AU2003238716A1 (en) 2003-12-31
CA2489269A1 (en) 2003-12-24
ES2314210T3 (es) 2009-03-16
EP1371362A1 (de) 2003-12-17
JP2005534663A (ja) 2005-11-17
CA2489269C (en) 2012-01-17

Similar Documents

Publication Publication Date Title
DE60323369D1 (de) Zusammensetzung zur behandlung entzündlicher erkrankungen
ATE319428T1 (de) Zusammensetzung zur behandlung von entzündlichen erkrankungen
BG104561A (en) Aryl fused azapolycyclic compounds
EP1539246A4 (de) Verabreichung in die zentralen luftwege zur systemischen abgabe von therapeutika
MY107157A (en) Quinuclidine derivatives.
AU2003258686A1 (en) Vesicle-encapsulated corticosteroids for the treatment of cancer
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
NO20063429L (no) Brusende oral opiat doseringsform
NO20031019L (no) Vedvarende frigivelsesformuleringer av oksymorfon
CY1110391T1 (el) Αρυλβινυλαζακυκλοαλκανια και μεθοδοι παρασκευης και χρησεως τους
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE69410121D1 (en) Dihydro pyrazolopyrrole
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BG106481A (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumour agents
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
IL152770A0 (en) Gabapentin analogues for sleep disorders
AR026487A1 (es) Derivados de espiro[2h-1-benzopiran-2,4'-piperidina] para el uso en terapia, especificamente para el tratamiento de alteraciones del snc
MY133474A (en) Aryl fused azapolycyclic compounds
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
WO2005003103A3 (en) 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
WO2003059376A8 (en) The use of il6r/il6 chimera in nerve cell regeneration
GB0019008D0 (en) Therapeutic compounds
SE0102639D0 (sv) Novel compounds
MY131159A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties